(Millions of yen) (Millions of U.S. dollars) Note 1 April 2012  (Transition date) 2013 2014 2014 Equity and liabilities Equity Share capital 25 ¥ 103,001 ¥ 103,001 ¥ 103,001 $ 1,000 Capital surplus 25 176,822 176,822 176,822 1,717 Treasury shares 25 (23,132) (72,285) (54,535) (529) Retained earnings 848,135 875,473 864,830 8,396 Other components of equity 25 20,332 91,596 178,359 1,732 Total equity attributable to owners of the parent 1,125,157 1,174,606 1,268,476 12,315 Total equity 1,125,157 1,174,606 1,268,476 12,315 Liabilities Non-current liabilities Trade and other payables 32 11,625 4,869 64 1 Deferred tax liabilities 18 17,550 15,270 2 0 Retirement benefit liabilities 28 24,843 32,201 27,184 264 Provisions 29 1,725 1,891 4,264 41 Other financial liabilities 30 1,509 1,391 749 7 Other non-current liabilities 31 6,731 10,142 11,681 113 Total non-current liabilities 63,983 65,765 43,944 427 Current liabilities Trade and other payables 32 199,263 201,762 187,032 1,816 Income tax payable 24,371 10,361 13,237 129 Provisions 29 32,442 48,089 66,407 645 Other financial liabilities 30 1,144 1,369 1,062 10 Other current liabilities 31 64,701 63,319 72,950 708 Total current liabilities 321,921 324,900 340,688 3,308 Total liabilities 385,904 390,665 384,632 3,734 Total equity and liabilities ¥1,511,061 ¥1,565,271 ¥1,653,108 $16,050 Financial Section Annual Report 2014 _  Astellas Pharma Inc.  105